RxDoctor Payments Data

Dagmara Osmanska-Jac, MD

Internal Medicine · Chelmsford, MANPI 1053413138

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 35th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$552,945
Medicare patients
553
Services billed
5,276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban46$23,639
XareltoRivaroxaban12$5,882
Enoxaparin Sodium49$3,183
Naloxone Hcl21$1,260
Atorvastatin Calcium92$889
Pantoprazole Sodium103$831
Baclofen25$617
Gabapentin81$613
Metoprolol Succinate58$570
Albuterol Sulfate HfaAlbuterol Sulfate22$564
Tamsulosin Hcl42$462
Midodrine Hcl11$382
Oxycodone Hcl88$287
Latanoprost16$251
Levothyroxine Sodium37$242

Paid to pharmacies, not to this prescriber.

Other internal medicine in Chelmsford

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →